Listing Gains
Latest news, explainers and analysis on Listing Gains. Tracking 11 stories on Arth Vani.
Connected in the graph
Latest on Listing Gains
IPOBreakingSonaselection India Leads 11 IPOs This Week, GMPs Hint at Up to 32% Returns
Sonaselection India - NSE is among 11 companies launching Initial Public Offerings (IPOs) this week, presenting numerous investment opportunities for Indian retail investors. Grey Market Premiums (GMPs) for these upcoming listings are signaling potential listing gains of up to 32%, indicating strong investor interest.
IPOBreakingGrey Market Signals: Kanohar Electricals, Glass Wall, Prasol Chemicals IPOs - Listing Gains?
The grey market premium (GMP) for upcoming IPOs of Kanohar Electricals, Glass Wall, and Prasol Chemicals offers early indications of potential listing gains. Investors are closely watching these unofficial indicators to gauge market sentiment and potential demand.
IPOBreakingMaharaja & Speedex India IPO Opens: GMP Hints at 16% Listing Gain for Investors
The Maharaja & Speedex India IPO has opened for public subscription with strong interest from institutional investors. Current Grey Market Premium (GMP) trends suggest a potential 16% listing gain for successful allottees.
IPOBreakingLumino Industries IPO Opens: GMP Signals 61% Gain; Firm to Raise ₹500 Crore
Lumino Industries has launched its ₹500 crore initial public offering today with a price band of ₹78-82 per share. Grey market trends suggest a strong listing premium of over 60% as the company seeks to utilize proceeds primarily for debt repayment.
IPOBreakingSunshine Pictures IPO Lists Today with Expected 13.89% Gain for Investors
Sunshine Pictures' Initial Public Offering (IPO) is scheduled to list today, June 18th, on the Indian stock exchanges. The shares are estimated to open around ₹410, potentially offering investors a significant 13.89% listing gain above the IPO price, following strong investor interest during its subscription period.
IPOBreakingLalithaa Jewellery Mart Lists at 32% Premium: Should You Hold or Sell After 36% Gains?
Lalithaa Jewellery Mart made a stellar debut on the stock exchanges, listing at ₹265.30, a 32% premium over its issue price of ₹201. While the stock surged further to 36.5% gains, initial profit booking has triggered questions on whether retail investors should exit or stay invested.
IPOBreaking20 IPOs to Hit Market Next Week: Grey Market Signals Up to 107% Listing Gains
The Indian primary market is set for a busy week with 20 IPOs scheduled for subscription and listing across mainboard and SME segments. Early grey market trends suggest massive listing gains, with some issues commanding premiums of over 100%.
IPOBreakingManipal Health Shares List at 11% Premium: Investors Book Gains on Market Debut
Manipal Health made a positive debut on the stock exchanges today, listing at a premium of over 11% against its issue price. The shares opened at ₹652 on the NSE and ₹655 on the BSE, rewarding successful allottees with immediate listing gains.
Horizon Reclaim IPO Listing: Investors Eye 73% Gains After Massive Subscription
Horizon Reclaim is set to debut on the stock exchanges today following a blockbuster IPO that saw demand far exceeding supply. With the grey market hinting at a 73% listing premium, retail investors who secured allotments are anticipating significant immediate returns.
UHM Vacation Debuts on Exchanges: Key Details as Listing Day Arrives
UHM Vacation is set to make its stock market debut today following a ₹36.02 crore public issue. Retail investors are closely watching the listing performance after the subscription window closed on June 8.
Hexagon Nutrition IPO: Retail Interest Surges on Day 2 with 15% Listing Gain Likely
The ₹139 crore public offer from Hexagon Nutrition is witnessing strong demand from individual investors, with the retail segment already oversubscribed. Current grey market trends suggest a positive debut for the nutrition-focused company on the stock exchanges.
Some listings may be sponsored and Arth Vani may earn a referral fee. All information is for educational purposes only — verify terms and suitability with the provider before acting. Not financial advice.